Abstract
The presence of pharmaceutical products in the environment is a global concern. These products enter into the environment through discharge from pharmaceutical industries, discharge from hospitals and research centers, domestic discharge, and improper disposal of pharmaceutical compounds. In the environment, these compounds enter into water bodies and are consumed by organisms, becoming part of the food chain. In addition, these products are found in the surface water, river, lake and are consumed by humans and animals. The existence of pharmaceutical compounds in the environment is associated with health risks to humans and animals and many other hazards such as the development of antibiotic resistance in microorganisms and changing reproductive and physiological behavior of organisms. Due to health concerns, the removal of pharmaceutical waste from wastewater is important and for this many approaches such as microfiltration, reverse osmosis, membrane bioreactor (MBR), etc., are being used. MBR-based wastewater treatment is an advanced and developed technological process for the mineralization of pharmaceuticals from wastewater. MBR utilizes membranes of various pore sizes for solid/liquid separation. Membrane separation technologies, along with bioreactors, have key applications in delivering excellent effluent quality with high operational reliability.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
